Zyban: A Clinically Proven Aid for Smoking Cessation
| Product dosage: 150mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.02 | $40.18 (0%) | 🛒 Add to cart |
| 20 | $3.01 | $80.36 $60.27 (25%) | 🛒 Add to cart |
| 30 | $2.34 | $120.54 $70.32 (42%) | 🛒 Add to cart |
| 60 | $1.34 | $241.09 $80.36 (67%) | 🛒 Add to cart |
| 90 | $1.00 | $361.63 $90.41 (75%) | 🛒 Add to cart |
| 120 | $0.84 | $482.17 $100.45 (79%) | 🛒 Add to cart |
| 180 | $0.75 | $723.26 $135.61 (81%) | 🛒 Add to cart |
| 270 | $0.67 | $1084.89 $180.82 (83%) | 🛒 Add to cart |
| 360 | $0.59
Best per pill | $1446.52 $210.95 (85%) | 🛒 Add to cart |
Similar products
Zyban (bupropion hydrochloride) is a prescription medication specifically developed to support adults in their journey to quit smoking. Unlike nicotine replacement therapies, Zyban works by affecting neurotransmitters in the brain associated with nicotine addiction and withdrawal. It reduces the urge to smoke and alleviates withdrawal symptoms, making it easier for individuals to break free from tobacco dependence. Clinical studies have demonstrated its efficacy when used as part of a comprehensive smoking cessation program that includes behavioral support and counseling.
Features
- Active ingredient: Bupropion hydrochloride
- Available in sustained-release tablets (150 mg)
- Non-nicotine based smoking cessation aid
- Requires a prescription from a healthcare provider
- Typically supplied in blister packs for accurate dosing
Benefits
- Reduces the severity of nicotine cravings and withdrawal symptoms
- Helps double the chances of long-term smoking cessation compared to placebo
- Does not contain nicotine, avoiding replacement dependency
- Can be used alongside behavioral support for a holistic approach
- May help prevent weight gain often associated with quitting smoking
- Supported by extensive clinical research and real-world evidence
Common use
Zyban is indicated as an aid to smoking cessation treatment in adults. It is intended for use in conjunction with motivational techniques, counseling, and other support measures as part of a structured quit plan. Treatment is usually initiated while the patient is still smoking, with a target quit date set within the first two weeks of therapy. It is not recommended for use in individuals under the age of 18.
Dosage and direction
The recommended dosage for Zyban is 150 mg once daily for the first three days, followed by 150 mg twice daily thereafter. Doses should be taken at least 8 hours apart to minimize the risk of insomnia. Tablets should be swallowed whole and not crushed, chewed, or divided. Treatment duration typically lasts 7 to 12 weeks, though some patients may benefit from longer therapy under medical supervision. Dosage adjustments may be necessary for patients with hepatic or renal impairment.
Precautions
Patients should be monitored for changes in behavior, emotional stability, and emergence of suicidal ideation, particularly when initiating therapy or changing doses. Use with caution in individuals with a history of seizure disorder, cranial trauma, or conditions that lower seizure threshold. Zyban may increase blood pressure; regular monitoring is advised. Alcohol consumption should be minimized or avoided due to increased seizure risk. Not recommended during pregnancy or breastfeeding unless potential benefits outweigh risks.
Contraindications
Zyban is contraindicated in patients with a current or prior diagnosis of bulimia or anorexia nervosa. It must not be used concomitantly with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy. Contraindicated in patients undergoing abrupt discontinuation of alcohol or sedatives. Should not be used in individuals with a known hypersensitivity to bupropion or any component of the formulation. Not recommended for patients with a history of seizure disorder.
Possible side effects
Common side effects may include dry mouth, insomnia, headache, nausea, and dizziness. Less frequently, patients may experience tremors, rash, sweating, or tinnitus. Serious side effects requiring immediate medical attention include seizures, severe allergic reactions, hallucinations, irregular heartbeat, or symptoms of hypertension. Some patients may experience mood changes, anxiety, or suicidal thoughts. Most side effects are mild to moderate and often diminish with continued use.
Drug interaction
Zyban has numerous potential drug interactions. It may interact with medications metabolized by CYP2D6 isoenzymes, including certain antidepressants, antipsychotics, beta-blockers, and antiarrhythmics. Concurrent use with other bupropion-containing products is contraindicated. May potentiate effects of levodopa and amantadine. Use caution with drugs that lower seizure threshold (e.g., antipsychotics, antidepressants, systemic corticosteroids). Avoid combination with other dopamine-norepinephrine reuptake inhibitors.
Missed dose
If a dose is missed, it should be skipped unless it is almost time for the next scheduled dose. Patients should never take a double dose to make up for a missed one. If unsure, they should contact their healthcare provider or pharmacist for guidance. Maintaining consistent dosing is important for therapeutic efficacy, but occasional missed doses are generally not critical if the regular schedule is promptly resumed.
Overdose
Overdose may lead to seizures, hallucinations, loss of consciousness, tachycardia, or cardiac arrest. Symptoms can include nausea, vomiting, and agitation. In case of suspected overdose, seek immediate medical attention. Treatment is supportive and may include gastric lavage, activated charcoal, and anticonvulsants if seizures occur. ECG monitoring is recommended due to potential cardiac effects. There is no specific antidote for bupropion overdose.
Storage
Store at room temperature (15–30°C or 59–86°F) in a dry place, protected from light and moisture. Keep in the original container with the lid tightly closed. Do not store in bathrooms or near sinks. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Proper disposal of unused medication is recommended through take-back programs or following FDA guidelines.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Zyban is a prescription medication and should only be used under the supervision of a qualified healthcare professional. Individual results may vary. Patients should consult their healthcare provider for personalized advice regarding smoking cessation strategies and potential treatment options. Never initiate or discontinue medication without professional guidance.
Reviews
Clinical trials demonstrate that Zyban significantly improves smoking cessation rates compared to placebo, with approximately 30–35% of users achieving abstinence at one year follow-up. Many patients report reduced withdrawal symptoms and fewer cravings. Some users note mild side effects during the initial treatment phase, though these often subside. Healthcare professionals frequently recommend Zyban as part of a comprehensive cessation program, emphasizing its non-nicotine mechanism and evidence-based efficacy. Long-term user satisfaction is generally high among those who successfully quit smoking.